BioCentury
ARTICLE | Clinical News

APD371: Phase I data

May 11, 2015 7:00 AM UTC

A double-blind, placebo-controlled Phase I trial in 56 healthy volunteers showed that single doses of 10-400 mg oral APD371 were well tolerated. ...